January 9, 2013—Health care providers in the federal 340B drug discount program came under intense scrutiny in 2012 and the focus is likely to remain sharp in the year ahead.
In the coming months, stakeholders can expect to see bills to reform 340B introduced by both champions and detractors of the program in Congress.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)